baber/WOPTO huggingface dataset:
Patent NZ-232919-A (NZ)
Title: Process for moulding multihardness foam article; dispensing two foams simultaneously into mould
Inventor: BROWN MICHAEL JOHN
IPC: B29K105/04
Filed: 1990-03-14
Abstract: The present invention concerns a process for preparing a multihardness foam article in a mould having the bottom surface flat or inclined up to 40 degrees to the horizontal plane. The process is characterized by the following steps:   (a) arranging a dispensing means, comprising at least two outlets for dispensing at least two foam formulations, the outlets being arranged in a line, and the distance between adjacent outlets being less than the width of the mould, so that the outlets move across the mould either at or near one of the edges of the flat bottom surface or at or near the top of the incline of the inclined bottom surface along the line defined by the outlets; (b) effective relative motion of the outlets across the mould along the line defined by the outlets; and (c) dispensing from each outlet simultaneously a foam formulation whilst the outle is directly above the inside of the mould.   The present process is particularly suitable for the preparation of a car seat comprising a layered foam seating area and single hardness or encapsulated foam side rolls in a single continous pouring operation.
Patent NZ-240768-A (NZ)
Title: Co-randomized fat compositions for infant formulas
Inventor: LIEN ERIC LOUIS
IPC: A23L35/00
Filed: 1991-11-27
Abstract: The invention disclosed herein comprises fat compositions primarily for use in nutritionally complete infant formulas in which the constituent palmitic acid oils and lauric acid oils are corandomized. The invention additionally includes such corandomized fat compositions with medium-chain triglycerides added, particularly for use in nutritional products for preterm or low birthweight infants. Such corandomization of two or more oils yields a mixture of triglycerides having a substantially different chemical makeup than that of the native oils themselves or than the native oils when randomized individually. Corandomization of the palmitic acid oils and the lauric acid oils affords an economical means of providing a very highly absorbed fat composition.
Patent NZ-242639-A (NZ)
Title: Asymmetric synthesis of 3-substituted furanoside compounds and intermediates
Inventor: RAIFELD YURI E
IPC: C07H11/00
Filed: 1992-05-07
Abstract: Novel processes, intermediates and reagents for the preparation of 3-substituted furanose or furanoside compounds of Formula I: <CHEM> wherein M is hydrogen or alkyl (C<5>-C<7>), A is halogen or A may be selected from a moiety of the formula: OR, SR, N<7>, SCR, OC-R or CN wherein R is hydrogen, branched or unbranched alkyl (C<5>-C<8>) or phenyl which compounds have antiviral and other biological activity.
Patent NZ-243304-A (NZ)
Title: Heterocyclic compounds, preparation and pharmaceutical compositions thereof
Inventor: TAKEHIKO NAKA
IPC: C07D403/10
Filed: 1992-06-25
Abstract: Compounds shown by the above formula or salt thereof show a strong angiotensin II antagonistic activity and hypotensive action and CNS activity, and are useful as therapeutic agents of circulatory diseases such as hypertensive diseases and heart diseases (e.g. hypercardia, heart failure, cardiac infarction), strokes, cerebral apoplexy, nephritis, atherosclerosis, Alzheimer's disease, senile dementia, etc. <CHEM> h
Patent NZ-251559-A (NZ)
Title: Baled waste paper recycling treatment: bales soaked in fiber softening and swelling fluid under vacuum
Inventor: STOCKEL IVAR HOWARD
IPC: D21B1/32
Filed: 1993-03-18
Abstract: A method and apparatus for reclaiming cellulosic fibers from a bale containing waste papers, in which the bale is positioned in a treatment enclosure, and the enclosure is placed under a vacuum. A treating fluid is drawn into the enclosure, which penetrates the bale interior spaces, and produces a preferential swelling-of uncontaminated cellulosic fibers. After the treating fluid is withdrawn from the enclosure, a slurrying fluid is passed through the bale contents, to form a fiber-fluid suspension slurry.
Patent NZ-262323-A (NZ)
Title: Food product casing imparts quilted surface pattern
Inventor: MERCURI ENRICO
IPC: D04B21/20
Filed: 1994-02-18
Abstract: PCT No. PCT/AU94/00076 Sec. 371 Date Oct. 31, 1995 Sec. 102(e) Date Oct. 31, 1995 PCT Filed Feb. 18, 1994 PCT Pub. No. WO94/18843 PCT Pub. Date Sep. 1, 1994This invention relates to a tubular casing for location around food products prior to cooking or curing that produce a quilted-like surface pattern to the surface of the food product. The invention comprises a first tubular portion that is knitted in continuous lengths such that the wall of the first tubular portion is stretchable, and circumferential and longitudinal threads secured to the surface of the first tubular portion that become taut as food product is located within the first tubular portion such that a quilted surface pattern is applied to the surface of the product.
Patent NZ-266499-A (NZ)
Title: N-phosphonomethylglycine preparation by hydrogenation then oxidation of n-phosphonomemethyl-2-oxazolidinone
Inventor: HODGKINSON IAN
IPC: B01J23/42
Filed: 1994-05-27
Abstract: N-Phosphonomethylglycine and its salts are manufactured by hydrolysing N-phosphonomethyl-2-oxazolidinone in an aqueous medium and thereafter oxidising the hydrolysis product in an aqueous alkaline medium using an oxygen-containing gas in the presence of an oxidation catalyst, for example a platinum or palladium catalyst optionally containing a promoter such as bismuth.
Patent NZ-291161-A (NZ)
Title: Transdermal drug delivery system comprising an adhesive, an estrogen, a flux enhancer and optionally a progestin
Inventor: FOTINOS SPIROS
IPC: A61K31/565
Filed: 1995-07-25
Abstract: PCT No. PCT/EP95/02938 Sec. 371 Date Jun. 19, 1996 Sec. 102(e) Date Jun. 19, 1996 PCT Filed Jul. 25, 1995 PCT Pub. No. WO96/03119 PCT Pub. Date Feb. 8, 1996A composition for use in a three layer transdermal delivery system is disclosed, the composition comprising an adhesive matrix having sufficient strength to maintain an association on the skin for at least 3 days. The adhesive matrix contains the flux enhancer linoleic acid, an anti-oxidant and an effective dose of one or more steroid hormones with female sex related activity.
Patent NZ-306091-A (NZ)
Title: Method and apparatus for castration using an endless elastic loop with non-resiliently deformed grommet
Inventor: CALLICRATE MICHAEL P
IPC: A61D1/06
Filed: 1996-03-22
Abstract: An apparatus and method for use in raising cattle, and in particular bulls, wherein bulls are: (a) fed a particularly nutritious liquid having a distinctive odor prior to weaning; (b) fed a combination of this liquid and conventional feed after weaning in a feedlot; (c) castrated using a ligation tool that provides a ligating tension to endless elastomeric ligation bands wherein the tool indicates the tension applied to such ligation bands; and (d) treated for infection prevention at least around the time of castration. Accordingly, cattle growth is accelerated due to enhanced nutrition, reduction in disease and a reduction in the stress upon the cattle. Furthermore, late castration of bulls (at approximately 5 to 14 months) is employed, wherein the tool of (c) provides a substantially stress-free ligation technique. Moreover, the meat produced from the cattle processed using the present invention has superior cutability characteristics.
Patent NZ-328973-A (NZ)
Title: use of substituted 3-benzyl-4-hydroxy-2H-1-benzopyran derivatives to prevent allograft rejection
Inventor: SHOWELL HENRY JAMES
IPC: C07D337/08
Filed: 1997-10-16
Abstract: The compound of formula I or its pharmaceutically acceptable salt is used in the manufacture of a medicament for suppressing the rejection of allogenic transplants in a mammal. In formula I: n is 1 to 3; A is O, S CH2 or NR; R is H or alkyl; B is CR4R5; R4 and R5 are independently H, alkyl, R6R7-alkyl or R6R7-alkoxy or together with the carbon to which they are attached form a cycloalkyl group;  R6 and R7 are independently H, alkyl, cycloalkyl or optionally substituted aryl or heteroaryl;  R1 is tetrazolyl, carboxy or optionally substituted carboxy-alkenyl alkyl, cycloalkyl or cycloalkylalkyl or is -[C(R8)(R9)]a-CO-NR10R11 or -(CH2)b-(Y)c-Z; R2 is H, F, Cl, alkyl, alkoxy, perfluoroalkyl, perfluroalkoxy, alkylthio, alkylsulphinyl, arylsulphinyl, alkylsulphonyl or arylsulphonyl and the rest of the variables are as defined in the specification.
Patent NZ-330741-A (NZ)
Title: Contraceptive process and kit for female mammals, comprising a combination of gestagen and oestrogen
Inventor: ENDRIKAT JAN
IPC: F16J15/00
Filed: 1996-12-20
Abstract: The present invention relates to a female mammal contraceptive process consisting of the sequential administration for at least 28 days of: (a)	a gestagen in an ovulation-preventing dose for at least 28 days in combination with (b)	a natural estrogen for 5 to 10 days at the end of the sequential dosage of at least 28 days, and a contraception kit. Preferably, the gestagen is contained in a daily dosage of  0.05-0.2mg of levonorgestrel or 0.05-0.15mg of gesodene.
Patent NZ-332295-A (NZ)
Title: Spray-dried hydrolyzed cellulose granulations for pharmaceuticals such as ibuprofen
Inventor: KARETNY MARC S
IPC: A61K9/20
Filed: 1997-04-15
Abstract: The present invention provides a method for obtaining a spray-dried compressible granular formulation for preparing pharmaceutical tablets in which hydrolyzed cellulose is used as a granulation aid, the resulting granulations, and pharmaceutical tablets compressed from such granules. In these formulations there is employed from 1 to 97 % by weight pharmaceutical active, from about 3 to 99 % by weight hydrolyzed cellulose, based on the dry weight of the granulation, and optionally conventional granulation and/or tableting additives such as surfactants, disintegrants and antiadherents/flow aids. The active ingredient is preferably, ibuprofen, acetominophen or pseudoephedrine.
Patent NZ-332596-A (NZ)
Title: Stabilising biologically active material in an amorphous carrier by convection drying
Inventor: GABEL ROLF-DIETER
IPC: B01D1/14
Filed: 1998-10-30
Abstract: The specification describes a process for producing dry, amorphous products which, besides therapeutically active material contain mixtures for stabilising the composition. The process is characterized in that a solution or suspension of the active and a mixture comprising i) a carbohydrate and at least one zwitterion with a polar or apolar radical or derivatives thereof and/or ii) at least two zwitterions with polar or apolar radicals or derivatives thereof and/or iii) at least one zwitterion with polar or apolar radical or a plurality of zwitterions with polar or apolar radicals or derivatives thereof is produced and dried by means of convection drying.  The moisture content is adjusted to less than 70% in the stationary phase at an inlet air temperature of 50-3000C.
Patent NZ-334282-A (NZ)
Title: Flavonol containing food supplements
Inventor: HOWARD ALAN NORMAN
IPC: A23K20/195
Filed: 1997-09-19
Abstract: A plant-derived dry composition obtained from grapes, wine or flavonol-containing by-products or waste-products of the wine-making process, wherein at least 25% w/w of the plant derived material in the composition comprises polyphenols, the composition as a whole comprising at least 0.01% w/w flavonol. The composition is useful for inhibiting oxidation of plasma LDL, stimulating TGF-beta production; inhibiting platelet aggregation and fibrinolsis.
Patent NZ-336792-A (NZ)
Title: Chelating immunostimulating complexes comprising a saponin preparation, a sterol, a phospholipid and a metal chelating moiety
Inventor: MACFARLAN RODERICK IAN
IPC: A61P37/04
Filed: 1998-02-13
Abstract: his immunostimulating complex matrix comprises a saponin preparation, a sterol and a phospholipid, where the matrix further comprises a metal-chelating moiety capable of binding a protein or polypeptide having at least one chelating amino acid sequence in the presence of metal ions. Also included is an immunogenic immunostimulating complex which comprises this matrix and an immunogenic protein or polypeptide having at least one chelating amino acid sequence, the protein or polypeptide being bound to the matrix in the presence of metal ions.  Divisional filed as 501460
Patent NZ-506952-A (NZ)
Title: System and method for enhanced short message service with node organising short messages based upon respective indicators
Inventor: ALPEROVICH VLADIMIR
IPC: H04W4/029
Filed: 1999-03-31
Abstract: A telecommunications system and method is disclosed for organizing SMS messages sent to a mobile terminal based on the location of the mobile terminal or the time of delivery of the SMS messages. Thus, when a subscriber sends a short message to another subscriber, the originating subscriber can specify the time of delivery of the message. In addition, the originating subscriber can specify the priority associated with the message, e.g., the SMS message can have an indication of priority one, which indicates to the receiving subscriber that the message is urgent. Furthermore, the originating subscriber can also specify that the message is to be delivered only when the called subscriber is in a certain location. The receiving subscriber can also control the display of the SMS messages by moving the received SMS messages to an action list, and then specifying when and/or where the SMS messages should be displayed again.
Patent NZ-507204-A (NZ)
Title: Substituted piperidine and piperazine derivatives having activity on muscarinic receptors
Inventor: DUGGENTO KATHARAN LAURI
IPC: A61P25/28
Filed: 1999-03-31
Abstract: A compound a pharmaceutically acceptable salt, ester or prodrug thereof has the formula (I) wherein: X1, X2, X3, X4 and X5 are independently C, N or O; k is O or 1 and t is 0, 1 or 2; R1 is alkyl, alkenyl, alkynyl, alkylidene, alkoxy, heteroalkyl, aminoalkyl, haloalkyl, alkoxycarbonyl, hydroxyalkoxy, hydroxyalkyl,-SH, alkylthio, -O-CH2-aryl, -C (O)-aryl substituted with alkyl or halo, C(O)NR3R4, - CR3R4R5, -OC(O)R3, -(O)(CH2)sNR3R4 or (CH2)sNR3R4; A is aryl or cycloalkyl, each optionally comprising 1 or more heteroatoms selected from N, S or O; R2 is H, amino, hydroxyl, halo, or alkyl, alkenyl, alkynyl, alkoxy, heteroalkyl, aminoalkyl, haloalkyl, alkoxycarbonyl, alkylthio, -CN, -CF3, -OR3, NHC(O)R3, -C(O)NR3R4, -NR3R4, - NR3C(O)NR4R5, -OC(O)R3, C-(O)R3, -O(CH2)qNR3, -CR5NR3R4 or -(CH2)qNR3R4; q is 1 to 6; n is 0 to 4 and the groups R2, when n > 1, are independent and p is 0 to 5; Y is O, S, CHOH, -NHC(O)-, -C(O)NH-, -C(O)-, -OC(O)-, NR7 or -CH=N-; Z is absent or is CR8R9 provided where -(CH2)p-Y- is -(CH2)3-C (O)- or -(CH2)3-S- and X1 to X5 are C -A-(R2)n and R1 are not together o- methyl-phenyl and n-butyl, respectively; phenyl and n- butyl, respectively or p-fluoro-phenyl and -O-(CH2)2CH3, respectively; R7 to R9, R3, R4 and Rs are as defined in the specification; The compounds are useful in treating neurogenerative disease, cognitive impairment, age-related cognitive decline, dementia or glaucoma.
Patent NZ-507574-A (NZ)
Title: Selective recovery of precious metals and copper from a medium loaded with precious metals and base metals
Inventor: JENKINS ALEXANDER E
IPC: C22B11/08
Filed: 1999-03-26
Abstract: Described is a process for the selective recovery of precious metals from a medium loaded with precious metals and base metals. The selective recovery of precious metals is achieved by exposing the medium to an aqueous solution containing a complex of formula MX2-, wherein M is a metal of group IB or IIB of the Periodic Table of Elements, and X is a monovalent radical. Also described is the removal of copper from the medium whereby elution of copper is achieved by exposing the medium to an aqueous solution capable of oxidising Cu(I) to Cu(II) whilst not eluting precious metals from the medium.
Patent NZ-508228-A (NZ)
Title: 2-aminopyrroline compounds characterised by presence of cyclopropyl group (e.g. N-(2-cyclopropylphenyl)-3,4-dihydro-2H-pyrrol-5-amine, N-(dicyclopropylmethyl)-3,4-dihydro-2H-pyrrol-5-amine or N-(2-cyclopropylphenyl)-2-methyl-3,4-dihydro-2H-pyrrol-5-amine for treating cardiovascular related diseases
Inventor: PFEIFFER BRUNO
IPC: C07D209/40
Filed: 2000-11-16
Abstract: Compounds having 2-aminopyrroline structure as shown; characterised by the presence of a cyclopropyl group associated with the aminopyrroline ring useful in the treatment of cardiovascular diseases, especially arterial hypertension, arrhythmia and associated disorders. Wherein; n is 1 or 2; X represents an alkylene, alkenylene or alkynylene group, or an optionally substituted arylene group, or an optionally substituted heteroarylene group; R10 represents a hydrogen atom or a linear or branched C1-6alkyl group and R11 and R12 together form a bond, or alternatively R12 represents a hydrogen atom or a linear or branched C1-6alkyl group and R10 and R11 together form a bond; R2, R3 and R4 each independently of the others represents a hydrogen atom, a linear or branched C1-6alkyl group, a linear or branched C1-6hydroxyalkyl group, a linear or branched C1-6alkoxy group, a linear or branched C1-6alkoxycarbonyl group, an optionally substituted aryl group, an optionally substituted arylalkyl group in which the alkyl moiety is linear or branched and has from 1 to 6 carbon atoms, or an optionally substituted aryloxyalkyl group in which the alkyl moiety is linear or branched and has from 1 to 6 carbon atoms, or alternatively two of R2, R3 and R4, with the carbon atoms carrying them, form a C5-7cycloalkyl group.
Patent NZ-515126-A (NZ)
Title: Shellfish opening apparatus with unopened or partially opened  shellfish  being opened and halves  separated  while being conveyed
Inventor: CORBIN DAVID WALTER
IPC: A22C29/04
Filed: 2001-10-29
Abstract: Shellfish halves 20a, 20b are conveyed along conveyor 1 towards  opening  plate  2.  An adjacent  upstream  rotating flipper  21  flips  upper half 20a through  substantially  a half  turn.  The  halves 20a, 20b are  then  conveyed  to  a separating  means (not shown) which breaks the halves  apart near the conveyor exit.
Patent NZ-515196-A (NZ)
Title: Method for increasing propionate in the gastro- intestinal tract
Inventor: JANN ALFRED
IPC: A23L29/269
Filed: 2000-05-19
Abstract: Described is the use of dextran in the preparation of a nutritional  composition  for  selectively  increasing   the production of propionate in the gastro-intestinal tract of a mammal. Also   described  is  the  use  of  dextran  in  nutritional compositions  for  decreasing blood  cholesterol  levels  in mammals  or  for  decreasing blood  triglyceride  levels  in mammals, where the nutritional composition further comprises inulin,  fructo-oligo  saccharide, galacto-oligosaccharides, or xylo-oligosaccharides, or mixtures thereof. Also described is the use of dextran in the preparation of a nutritional  composition  for decreasing  very  low  density lipoprotein  levels  in  mammals,  or  for  increasing  high density  lipoprotein levels in mammals,  or  for  increasing insulin sensitivity in mammals.
Patent NZ-515384-A (NZ)
Title: Fluorescence polarization assays involving polyions
Inventor: NIKIFOROV THEO T
IPC: C12Q1/68
Filed: 2000-05-11
Abstract: Methods, systems, kits for carrying out a wide variety of different assays that comprise providing a first reagent mixture which comprises a first reagent having a fluorescent label. A second reagent is introduced into the first reagent mixture to produce a second reagent mixture, where the second reagent reacts with the first reagent to produce a fluorescently labeled product having a substantially different charge than the first reagent. A polygon is introduced into at least one of the first and second reagent mixtures, and the fluorescent polarization in the second reagent mixture relative to the first reagent mixture is determined, this fluorescent polarization being indicative of the rate or extent of the reaction
Patent NZ-525865-A (NZ)
Title: Well connection tubing containing an insert, insert having the connection wire in a groove
Inventor: HUGHES WILLIAM JAMES
IPC: E21B17/00
Filed: 2003-05-14
Abstract: Apparatus for providing tubing with transmission capability, the tube having a first end and a second end and an inside and an outside. A cylindrical insert is engaged with the inside of the tubing, the insert has a groove running lengthwise and a wire is disposed within the groove.
Patent NZ-532438-A (NZ)
Title: Methods for producing proteinaceous molecules in a mammalian cell comprising a predetermined post-translational modification
Inventor: OPSTELTEN DIRK JAN ELBERTUS
Filed: 2002-10-29
Abstract: Described are methods for identifying, selecting and obtaining mammalian cells that are capable of producing proteinaceous molecules comprising predetermined post-translational modifications, wherein said post-translational modifications are brought about by the mammalian cell in which the proteinaceous molecule is expressed. Preferably, the predetermined post-translational modifications comprise glycosylation. Further described are methods for obtaining and producing proteinaceous molecules, using mammalian cells obtained by the method described. Preferably, the proteinaceous molecules comprise erythropoietin (EPO), since the effect of (recombinant) EPO depends heavily on the glycosylation pattern of the oligosaccharides present on the protein. Mammalian cells that have been obtained on the basis of their ability to produce proteins and/or post-translational modifications that are indicative for a predetermined post-translational modification that is desired are also provided. Preferably, the mammalian cells have neural characteristics and properties such that significant amounts of recombinant proteins can be produced that harbour 'neural- or brain-type' properties.
Patent NZ-532827-A (NZ)
Title: Chemokine receptor antagonists and methods of use thereof
Inventor: NAKASATO YOSHISUKE
IPC: A61K31/4353
Filed: 2002-11-13
Abstract: Disclosed are compounds of formula I which may be used in the treatment of a disease associated with aberrant leukocyte recruitment and/or activation.
Patent NZ-533858-A (NZ)
Title: Laser scanning for mooring robot
Inventor: MONTGOMERY PETER JAMES
IPC: G01S13/88
Filed: 2004-06-29
Abstract: A profile scanner (100) for determining a target zone (112) on a vessel (110) to be docked by a mooring robot (104) is disclosed. The scanner includes an emitter radiating towards the vessel and a receiver to provide a signal to a processor for determining the vertical location of the target zone. The automatically identified target zone is an area on the vessel suitable for engagement by the mooring robot during docking.
Patent NZ-534592-A (NZ)
Title: Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
Inventor: BALDRIDGE JORY R
IPC: A61P31/04
Filed: 2002-02-04
Abstract: Disclosed is the use of one or more compounds having the formula (I) and pharmaceutically acceptable salts thereof, wherein: X is a member selected from the group consisting of -O- and -NH; Y is a member selected from the group consisting of -O- and -S-; R1, R2 and R3 are each members independently selected from the group consisting of (C2-C20)acyl; R4 is a member selected from the group consisting of -H and -PO3R7R8, wherein R7 and R8 are each members independently selected from the group consisting of -H and (C1-C4) aliphatic groups; R6 is selected from H, OH, (C1-C4)oxyaliphatic groups, -PO3R11R12, -OPO3R11R12, -SO3R11, -OSO3R11, -NR11R12, -SR11, -CN, -NO2, -CHO, -CO2R11 and -CONR11R12; for the manufacture of a medicament for ameliorating or substantially preventing an infectious disease, autoimmune disease or allergic condition in a subject.